|
Canada-0-FORGINGS Azienda Directories
|
Azienda News:
- Our leadership team - Bristol Myers Squibb
Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders
- Bristol Myers Squibb CEO Chris Boerner says company culture . . . - Fortune
When Chris Boerner became CEO and board chair of Bristol Myers Squibb (No 94 on the Fortune 500) two years ago, he took over a storied pharmaceutical company with roots in supplying pain
- Bristol Myers Squibb’s Post - LinkedIn
Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he’ll succeed Giovanni Caforio as Chair of the Board of Directors
- Bristol Myers Squibb Appoints Christopher Boerner, Ph. D. , to Chair of . . .
Boerner was named Executive Vice President, Chief Operating Officer and CEO-elect on April 26 and, as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb
- Chris Boerner, PhD 02, Board Chair CEO, Bristol Myers Squibb - Haas . . .
By pursuing meaningful work and valuing the people around him, says Chris Boerner, who was recently named board chair and CEO of Bristol Myers Squibb (BMS) Boerner swore off science after completing a college biology course and instead majored in economics and history
- Bristol Myers Squibb CEO and Key Executive Team - Craft. co
Bristol Myers Squibb's Chief Executive Officer and Director is Chris Boerner Other executives include Sandra Leung, Executive Vice President, General Counsel; David Elkins, Executive Vice President and Chief Financial Officer and 47 others See the full leadership team at Craft
- Bristol-Myers Squibb Company (BMY) Leadership Management Team . . .
Learn about Bristol-Myers Squibb Company (BMY) stock's management team Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team
- Bristol Myers Squibb Appoints Boerner CEO Chairperson
Boerner was named executive vice president, chief operating officer and CEO-elect on April 26 and, as of Nov 1, Boerner will be CEO of Bristol Myers Squibb “I am honored to become CEO and later board chair,” said Boerner
- Chris Boerner, PhD - Bristol Myers Squibb
Learn more about Chris Boerner, PhD, board chair and chief executive officer at Bristol Myers Squibb Leading with innovation to deliver vital medicines worldwide
- MIT SHBC SHIP
Christopher Boerner is board chair and chief executive officer at Bristol Myers Squibb Prior to assuming his current role, he served as executive vice president, chief operating officer and chief executive officer designate from April to November 2023
|
|